HIV / AIDS
EACS 2017: How a London Clinic Reduced New HIV Infections by 90%
- Details
- Category: Search for a Cure
- Published on Friday, 27 October 2017 00:00
Scaling up HIV testing to reduce undiagnosed HIV infection requires a fundamental re-ordering of HIV testing services to make them more attractive to people at risk, and doing so can bring about enormous changes in HIV incidence and treatment uptake, delegates heard on the opening day of the 16th European AIDS Conference (EACS 2017) in Milan in October.
IAS 2017: Why Curing Cancer May Be Like Curing HIV -- and May Be As Difficult
- Details
- Category: Search for a Cure
- Published on Thursday, 12 October 2017 00:00
For the last few years, a specialist symposium on HIV cure research has preceded the annual International AIDS Society meetings, and this year was no exception, with a 2-day forum at the Curie Institute in Paris before the opening of the 9th IAS Conference on HIV Science (IAS 2017).
Virally Suppressed People Have "Effectively No Risk" of Transmitting HIV, Says CDC
- Details
- Category: HIV Prevention
- Published on Thursday, 12 October 2017 00:00
The US Centers for Disease Control and Prevention (CDC) announced on September 27, National Gay Men’s HIV/AIDS Awareness Day, that HIV diagnoses had fallen among white gay and bisexual men and remained stable among African-American gay men between 2010 and 2014, its last complete year of figures.
IDWeek 2017: Long-Acting Monoclonal Antibody Effective Against Multidrug-Resistant HIV
- Details
- Category: HIV Treatment
- Published on Thursday, 12 October 2017 00:00
Ibalizumab, a long-acting monoclonal antibody that prevents HIV from entering cells, maintained viral suppression for a year in people with highly resistant HIV and limited treatment options, according to a presentation at the IDWeek 2017 conference last week in San Diego.
IAS 2017: Cancer Research May Offer Clues for HIV Cure Research -- and Vice Versa
- Details
- Category: Search for a Cure
- Published on Thursday, 12 October 2017 00:00
There is a growing overlap between the fields of cancer and HIV cure research, and approaches that help fight one disease may offer clues about the other. This convergence was the theme of the HIV Cure and Cancer Forum preceding the International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris -- the first time cancer has joined the HIV cure agenda.
IDWeek 2017: Single-Tablet Protease Inhibitor Regimen Maintains Viral Suppression for a Year
- Details
- Category: HIV Treatment
- Published on Thursday, 12 October 2017 00:00
People who switched from a multi-pill antiretroviral regimen to the first 1-pill, once-daily regimen that includes a protease inhibitor maintained undetectable viral load for a year, according to a report at the IDWeek 2017 conference last week in San Diego.
No New HIV Infections Among Kaiser PrEP Users, But Cascade Shows Missed Opportunities
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 21 September 2017 00:00
No new HIV infections have occurred among nearly 5000 people who started Truvada for pre-exposure prophylaxis (PrEP) in the Kaiser Permanente Northern California health system, according to a letter in the July 29 edition of Clinical Infectious Diseases.
More Articles...
- IAS 2017: Experts Agree that Intermittent Oral PrEP Probably Won't Work for Women
- IAS 2017: Switch from Boosted Protease Inhibitor to Dolutegravir Reduces Lipids in People with HIV
- IAS 2017: Who Are Trans Women Acquiring HIV From?
- CDC Continues to Recommend Annual HIV Testing for Gay Men
- San Francisco Annual Report Shows Continued Drop in HIV Infections
Web Design and Development by